Lv61
2390 积分 2023-05-11 加入
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
7天前
已完结
Remibrutinib in Chronic Spontaneous Urticaria
4个月前
已完结
A review on renal autologous cell transplantation: an investigational approach towards chronic kidney disease
4个月前
已完结
Cell and gene therapy for kidney disease
4个月前
已完结
Precision epigenetic editing: Technological advances, enduring challenges, and therapeutic applications
6个月前
已完结
Epigenome editing technologies for discovery and medicine
7个月前
已完结
Advances in CRISPR-Cas systems for epigenetics
7个月前
已完结
Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review
8个月前
已完结
Promising phase II biologics for future Crohn’s disease therapy
8个月前
已完结
Recent advances in the treatment of IBD: Targets, mechanisms and related therapies
8个月前
已完结
皖公网安备34019202002308
